Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance von Zitvogel, Laurence, Galluzzi, Lorenzo, Smyth, Mark J., Kroemer, Guido

Volltext

Balancing natural killer cell activation through paired receptors von Martinet, Ludovic, Smyth, Mark J.

Volltext

Targeting natural killer cells in cancer immunotherapy von Guillerey, Camille, Huntington, Nicholas D, Smyth, Mark J

Volltext

Cancer immunoediting and immune dysregulation in multiple myeloma von Nakamura, Kyohei, Smyth, Mark J., Martinet, Ludovic

Volltext

Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion von Schreiber, Robert D., Old, Lloyd J., Smyth, Mark J.

Volltext

Targeting cancer‐related inflammation in the era of immunotherapy von Nakamura, Kyohei, Smyth, Mark J

Volltext

The pre-metastatic niche: finding common ground von Sceneay, Jaclyn, Smyth, Mark J., Möller, Andreas

Volltext

Co-inhibition of CD73 and A2AR Adenosine Signaling Improves Anti-tumor Immune Responses von Young, Arabella, Ngiow, Shin Foong, Barkauskas, Deborah S., Sult, Erin, Hay, Carl, Blake, Stephen J., Huang, Qihui, Liu, Jing, Takeda, Kazuyoshi, Teng, Michele W.L., Sachsenmeier, Kris, Smyth, Mark J.

Volltext

Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites von Gerbe, François, Sidot, Emmanuelle, Smyth, Danielle J., Ohmoto, Makoto, Matsumoto, Ichiro, Dardalhon, Valérie, Cesses, Pierre, Garnier, Laure, Pouzolles, Marie, Brulin, Bénédicte, Bruschi, Marco, Harcus, Yvonne, Zimmermann, Valérie S., Taylor, Naomi, Maizels, Rick M., Jay, Philippe

Volltext

TIGIT and CD96: new checkpoint receptor targets for cancer immunotherapy von Dougall, William C., Kurtulus, Sema, Smyth, Mark J., Anderson, Ana C.

Volltext

IL-12 and IL-23 cytokines: from discovery to targeted therapies for immune-mediated inflammatory diseases von Teng, Michele W L, Bowman, Edward P, McElwee, Joshua J, Smyth, Mark J, Casanova, Jean-Laurent, Cooper, Andrea M, Cua, Daniel J

Volltext

Targeting CD73 Enhances the Antitumor Activity of Anti-PD-1 and Anti-CTLA-4 mAbs von ALLARD, Bertrand, POMMEY, Sandra, SMYTH, Mark J, STAGG, John

Volltext

Mechanism of action of immunomodulatory drugs (IMiDS) in multiple myeloma von Quach, H, Ritchie, D, Stewart, A K, Neeson, P, Harrison, S, Smyth, M J, Prince, H M

Volltext

Natural innate and adaptive immunity to cancer von Vesely, Matthew D, Kershaw, Michael H, Schreiber, Robert D, Smyth, Mark J

Volltext

Targeting immune checkpoints in hematological malignancies von Salik, Basit, Smyth, Mark J, Nakamura, Kyohei

Volltext

Molecular Pathways: Targeting CD96 and TIGIT for Cancer Immunotherapy von Blake, Stephen J, Dougall, William C, Miles, John J, Teng, Michele W L, Smyth, Mark J

Volltext

Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial von Loi, S., Michiels, S., Salgado, R., Sirtaine, N., Jose, V., Fumagalli, D., Kellokumpu-Lehtinen, P.-L., Bono, P., Kataja, V., Desmedt, C., Piccart, M.J., Loibl, S., Denkert, C., Smyth, M.J., Joensuu, H., Sotiriou, C.

Volltext

The TRAIL apoptotic pathway in cancer onset, progression and therapy von Johnstone, Ricky W, Smyth, Mark J, Frew, Ailsa J

Volltext

Molecular mechanisms of natural killer cell activation in response to cellular stress von Chan, C J, Smyth, M J, Martinet, L

Volltext

BK Polyomavirus: Clinical Aspects, Immune Regulation, and Emerging Therapies von Ambalathingal, George R, Francis, Ross S, Smyth, Mark J, Smith, Corey, Khanna, Rajiv

Volltext